Wetenschappelijke publicaties van Bordet

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.
Auteurs Pop CF, Ortega C, Lecomte M, Kristanto P, Khaled C, De Neubourg F, Desmet A, De Azambuja E, Larsimont D, Veys I
Auteurs (entité) DESMET ANTOINE
Revue NPJ Breast Cancer
Date de publication 2025-05

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.
Auteurs Khaled C, Safar L, Hendlisz A, Gomez Galdon M, Kristanto P, Moreau M, Veron Sanchez A, Liberale G
Auteurs (entité) GOMEZ GALDON MARIA
Revue Acta Chir Belg
Date de publication 2025-05

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.
Auteurs Khaled C, Safar L, Hendlisz A, Gomez Galdon M, Kristanto P, Moreau M, Veron Sanchez A, Liberale G
Auteurs (entité) VERON SANCHEZ ANA
Revue Acta Chir Belg
Date de publication 2025-05

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.
Auteurs Khaled C, Safar L, Hendlisz A, Gomez Galdon M, Kristanto P, Moreau M, Veron Sanchez A, Liberale G
Auteurs (entité) LIBERALE GABRIEL
Revue Acta Chir Belg
Date de publication 2025-05

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.
Auteurs Khaled C, Safar L, Hendlisz A, Gomez Galdon M, Kristanto P, Moreau M, Veron Sanchez A, Liberale G
Auteurs (entité) MOREAU MICHEL
Revue Acta Chir Belg
Date de publication 2025-05

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.
Auteurs Khaled C, Safar L, Hendlisz A, Gomez Galdon M, Kristanto P, Moreau M, Veron Sanchez A, Liberale G
Auteurs (entité) HENDLISZ ALAIN
Revue Acta Chir Belg
Date de publication 2025-05

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

[ 18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.
Auteurs Chan DL, Hayes A, Karfis I, Conner A, Mileva M, Bernard E, Navalkissoor S, Gnanasekaran G, Clarke SJ, Roach PJ, Flamen P, Caplin ME, Pavlakis N, Toumpanakis C, Bailey DL
Auteurs (entité) FLAMEN PATRICK
Revue J Nucl Med
Date de publication 2025-05

[ 18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

[ 18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.
Auteurs Chan DL, Hayes A, Karfis I, Conner A, Mileva M, Bernard E, Navalkissoor S, Gnanasekaran G, Clarke SJ, Roach PJ, Flamen P, Caplin ME, Pavlakis N, Toumpanakis C, Bailey DL
Auteurs (entité) KARFIS IOANNIS
Revue J Nucl Med
Date de publication 2025-05

[ 18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.
Auteurs Raicevic Toungouz G, Alessandrello R, Giacomini P, Kamal M, Gausachs M, Mazzarella L, Sujobert P, Frigè G, Alay A, Planchon JM, Blau O, Mias Carballal MR, Antoine-Poirel H, Nadal E, Bullinger L, Hebrant A, Servant N, D'Haene N, Aftimos P, Silkenstedt E, Michalík A, Dupain C, Delcourt T, Huet S, Van Campenhout C, Cordero D, Castellano Garcia JM, Codony C, Krol A, Gonzalo J, Van Damme N, Delnord M, Carbone R, Trapani V, Van Garsse S, Van Den Bulcke M
Auteurs (entité) AFTIMOS PHILIPPE
Revue ESMO Open
Date de publication 2025-05

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

[ <sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

[ <sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.

Erasmusziekenhuis

Queen Fabiola Kinderziekenhuis

Jules Bordet-instituut

Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

Surgical management of Pseudomyxoma peritonei: Low-volume center experience.

[ <sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

[ <sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.

Erasmusziekenhuis

Queen Fabiola Kinderziekenhuis

Jules Bordet-instituut

Search for a keyword

Please select a hospital